JF
NUVB icon

Jump Financial’s Nuvation Bio NUVB Stock Holding History

Jump Financial’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.72M Buy
1,358,411
+1,095,854
+417% +$5.36M 0.06% 349
2026
Q1 		$1.13M Buy
262,557
+92,957
+55% +$518K 0.02% 876
2025
Q4 		$1.52M Buy
+169,600
New +$1.05M 0.02% 800
2025
Q1 		– Sell
-21,460
Closed -$57.1K – 1883
2024
Q4 		$57.1K Sell
21,460
-12,213
-36% -$31.4K ﹤0.01% 1565
2024
Q3 		$77.1K Buy
+33,673
New +$103K ﹤0.01% 1538
2022
Q2 		– Sell
-124,300
Closed -$654K – 1894
2022
Q1 		$654K Buy
+124,300
New +$698K 0.03% 695

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jump Financial's NUVB Position: Q2 2026 in Review

Jump Financial increased its Nuvation Bio (NUVB) stake by 417% in Q2 2026, buying an estimated $5.36M and bringing the position to 1,358,411 shares worth $7.72M. The position accounts for 0.06% of the portfolio, ranked #349.

Jump Financial first reported a position in NUVB in Q1 2022 and has held it in 6 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Jump Financial held 1,358,411 shares of Nuvation Bio worth $7.72M as of Q2 2026.
  • Jump Financial bought 1,095,854 Nuvation Bio shares in Q2 2026, an estimated $5.36M.
  • Nuvation Bio made up 0.06% of Jump Financial's portfolio in Q2 2026, its #349 holding.
  • Jump Financial first reported a position in Nuvation Bio in Q1 2022 and has held it in 6 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.